# Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Canonical URL: https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-secures-second-1-million-strategic-placement-total-2-million-raised-in-february
Ticker: BCLI
Company: Brainstorm Cell Therapeutics Inc.
Source: Brainstorm Cell Therapeutics Inc.
Published: 2026-02-26 11:22 EST
Original Source URL: https://ir.brainstorm-cell.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-28 12:00 EST — [BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman](https://biopharmsignal.com/news/BCLI/brainstorm-appoints-former-fda-associate-commissioner-peter-j-pitts-as-executive-0d7242f8) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-06-02 13:00 EST — [BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-publication-calling-for-updated-fda-approaches-to-als-rare-diseases-and-regenerative-medicine) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-28 11:45 EST — [BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-appoints-former-fda-associate-commissioner-peter-j-pitts-to-board-of-directors) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-19 12:00 EST — [BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-aggregate-of-400-000-in-private-placements-priced-at-premium-to-market) — Source: Brainstorm Cell Therapeutics Inc.
- 2026-05-15 20:05 EST — [BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Brainstorm Cell Therapeutics Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)